-
-
-
-
-
-
-
Novartis to acquire Tourmaline Bio, complementing cardiovascular pipeline with pacibekitug for the treatment of atherosclerotic cardiovascular disease (ASCVD)
5,309 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

